Perrigo | PRGO - Выручка от реализации





Продажи Изменить Дата
AbbVie USD 15B 1.62B 2026-03
Abbott USD 11.16B 300M 2026-03
Bayer EUR 13.41B 1.97B 2026-03
Bristol-Myers Squibb USD 11.49B 1.01B 2026-03
Coherus Biosciences USD 12.75M 1.18M 2025-12
Corcept Therapeutics USD 164.9M 37.22M 2026-03
Dr.Reddys Laboratories INR 87.27B 780M 2025-12
Eli Lilly USD 19.8B 500M 2026-03
J&J USD 24.1B 500M 2026-03
Merck USD 16.29B 110M 2026-03
Nestle CHF 45.26B 1.03B 2025-12
Pacira USD 177M 19.87M 2026-03
Perrigo USD 969M 141M 2026-03
Pfizer USD 14.5B 3.08B 2026-03
Phibro Animal Health USD 373.91M 10.02M 2025-12
Prestige Brands USD 283.44M 9.34M 2025-12
Reckitt Benckiser GBP 7.26B 3.96B 2025-12
Sanofi EUR 11.24B 60M 2026-03
Supernus Pharmaceuticals USD 207.71M 3.89M 2026-03
Teva Pharmaceutical Industries USD 11.77B 2.86B 2026-03
Xeris Pharmaceuticals USD 83.13M 2.68M 2026-03
Zoetis USD 2.3B 100M 2026-03